Same old story

A new German study of the controversial chemical features a familiar problem. April 28, 2011 7:48 p.m. An old and familiar problem emerges in a new study concluding the controversial chemical bisphenol A is safe: Some of the study’s authors have ties to the...

Same old story

A new German study of the controversial chemical features a familiar problem. April 28, 2011 7:48 p.m. An old and familiar problem emerges in a new study concluding the controversial chemical bisphenol A is safe: Some of the study’s authors have ties to the...

FDA approves Zytiga for late-stage prostate cancer

The U.S. Food and Drug Administration today approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).

FDA approves Zytiga for late-stage prostate cancer

The U.S. Food and Drug Administration today approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).